Please assess the completion status of the following clinical trial:

Trial Title: Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Have used and/or desired to use an artificial tear substitute for dry eye symptoms within 6 months prior to the Screening Visit~* Normal lid/lash anatomy, blinking function and closure as determined by the Investigator~* Literate, able to speak English, and able to complete questionnaires independently~Exclusion Criteria:~* Chronic or recurrent epistaxis, coagulation disorders or other conditions that, in the opinion of the Investigator, may lead to risk of clinically significant increased bleeding~* Nasal or sinus surgery (including history of application of nasal cautery) or significant trauma to these areas~* Contact lens use within 7 days prior to the Screening Visit or anticipate the use of contact lenses at any time during the study~* Corneal transplant in either or both eyes~* Cardiac demand pacemaker, implanted defibrillator, or other active implanted metallic or active implanted electronic device in the head~* A woman who is pregnant, nursing an infant, or planning a pregnancy during the duration of the study~* Currently enrolled in an investigational drug or device study or have used an investigational drug or device within 30 days prior to the Screening Visit

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TrueTear (Type: EXPERIMENTAL): The device delivers small electrical currents, activating nerves that stimulate the body's natural tear production system.

Based on this trial design, predict the completion outcome and termination type (if applicable).